NIS - libdoc.who.int - World Health Organization

WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS)
63. Hiller KO, Ghorbani M, Schilcher H. Antispasmodic and relaxant activity
of chelidonine, protopine, coptisine, and Chelidonium majus extracts on
isolated guinea-pig ileum. Planta Medica, 1998, 64:758–760.
64. Boegge S et al. Reduction of ACh-induced contraction of rat isolated ileum
by coptisine, (+)-caffeoylmalic acid, Chelidonium majus, and Corydalis lutea
extracts. Planta Medica, 1996, 62:173–174.
65. Piacente S et al. Different effects of some isoquinoline alkaloids from Argemone
mexicana on electrically induced contractions of isolated guinea-pig
ileum. Phytotherapy Research, 1997, 11:155–157.
66. Vahlensieck U et al. The effect of Chelidonium majus herb extract on choleresis
in the isolated perfused rat liver. Planta Medica, 1995, 61:267–270.
67. Kim Y et al. Modulation of Chelidonii herba on GABA activated chloride
current in rat PAG neurons. American Journal of Chinese Medicine, 2001,
29:265-279.
68. Haberlein H et al. Chelidonium majus l. Components with in vitro affinity
for the GABA receptor. Positive cooperation of alkaloids. Planta Medica,
1996, 62:227–231.
69. Kim DJ et al. Potential preventive effects on Chelidonium majus l. (Papaveraceae)
herb extract on glandular stomach tumour development in rats
treated with N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) and hypertonic
sodium chloride. Cancer Letters, 1997, 112:203–208.
70. Song JY et al. Immunomodulatory activity of protein-bound polysaccharide
extracted from Chelidonium majus. Archives of Pharmacology, 2002,
25:158–164.
71. Spiridonov NA et al. Cytotoxicity of some Russian ethnomedical plants and
plant compounds. Phytotherapy Research, 2005, 19:428–432.
72. Saglam H, Arar G. Cytotoxic activity and quality control determinations on
Chelidonium majus. Fitoterapia, 2003, 74:127–129.
73. Jagiello-Wojtowicz E et al. Preliminary pharmacological evaluation of Chelidonine
in rodents. Polish Journal of Pharmacology and Pharmacy, 1989,
41:125–131.
74. Kim JH et al. Studies on the acute oral toxicity and anti-inflammatory activity
of extract of Chelidonii Herba from Korea. Herba Chelidonii. Report of
CFDSR WonKwang University, 1995, 8:7–18.
75. Kosina P et al. Sanguinarine and chelerythrine: assessment of safety on pigs
in ninety days feeding experiment. Food and Chemical Toxicology, 2004,
42:85–91.
76. Dalvi RR. Sanguinarine: its potential as a liver toxic alkaloid present in the
seeds of Agremone mexicana. Experientia, 1985, 41:77–78.
77. Ulrichova J et al. Cytotoxicity of benzo[c]phenanthridinium alkaloids in
isolated rat hepatocytes. Phytotherapy Research, 1996, 10:220–223.
78. Greving I et al. Chelidonium majus: a rare reason for severe hepatotoxic reaction.
Pharmacoepidemiology and Drug Safety, 1998, 7:566–569.
88